GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
52.82 +0.50  +0.96% NYSE Apr 16, 8:00PM BATS Real time Currency in USD

GlaxoSmithKline Shareholders Equity (Quarterly):

11.53B for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Shareholders Equity (Quarterly) Chart

Export Data
Save Image

GlaxoSmithKline Historical Shareholders Equity (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 11.53B
Sept. 30, 2013 9.581B
June 30, 2013 9.784B
March 31, 2013 10.17B
Dec. 31, 2012 9.347B
Sept. 30, 2012 10.10B
June 30, 2012 10.94B
March 31, 2012 14.01B
Dec. 31, 2011 12.38B
Sept. 30, 2011 11.59B
June 30, 2011 13.88B
March 31, 2011 14.52B
Dec. 31, 2010 13.78B
Sept. 30, 2010 15.50B
June 30, 2010 13.20B
March 31, 2010 16.08B
Dec. 31, 2009 16.08B
Sept. 30, 2009 14.82B
June 30, 2009 12.79B
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Shareholders' Equity

Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More

Get data for
Advertisement

GSK Shareholders Equity (Quarterly) Benchmarks

Companies
AstraZeneca 23.22B
Eli Lilly 17.63B
Johnson & Johnson 74.05B

GSK Shareholders Equity (Quarterly) Range, Past 5 Years

Minimum 9.347B Dec 2012
Maximum 16.08B Mar 2010
Average 12.64B
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.